Stock Chart

BDTX

$1.96 +1.55%
Score: 52.9 HOLD
Pro
Screener
Vol: 2.15x (vs SPY: 1.1x | vs QQQ: 1.4x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Sep 18, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About BDTX - Black Diamond Therapeutics, Inc. Common Stock

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Key Statistics

Market Cap $111M

This BDTX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track BDTX's price movements with trendlines, gamma walls, and key support/resistance levels.